Celldex Therapeutics shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Schonfeld Strategic Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.2M | 131k | 39.66 |
| 2022-12-31 | $636k | 14k | 44.57 |
| 2022-03-31 | $481k | 14k | 34.11 |
| 2021-12-31 | $527k | 14k | 38.63 |
| 2021-09-30 | $3.1M | 57k | 54.01 |
| 2021-06-30 | $2.6M | 77k | 33.44 |
| 2021-03-31 | $712k | 35k | 20.60 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors